Latest Breaking News On - Bridgebio pharma - Page 8 : comparemela.com

Certuity LLC purchased a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,400 shares of the company’s stock, valued at approximately $258,000. Several other hedge funds have also added […]

New zealand generalNew zealandBio pharmaRandalw scottNorthern trust corpPrimecap management coCantor fitzgeraldCharles schwab investment management incSecurities exchange commissionBio pharma incExchange commissionWellington management groupBridgebio pharma incLord abbettBridgebio pharmaFree report